Validation · 2026
36/36 blind predictions correct across 5 independent peer-reviewed datasets. Every call time-stamped and cryptographically locked before the literature was checked.
2026
Pipeline · Jul 2026
Single HARMONY scaffold shows confirmed activity across four consecutive MAPK cancer pathway targets. No approved drug currently covers this combination.
July 2026
IP · Jul 2026
7 USPTO provisional patents confirmed.
July 2026
Wet Lab · Jun 2026
ABCC8/SUR1 wet lab validation signed and executing at Scientist.com. First prospective results targeting Q4 2026.
June 2026
Discovery · 2026
HARMONY independently re-derived tolbutamide — the first FDA-approved sulfonylurea, approved in 1957 — from protein backbone physics alone. Zero prior knowledge of its pharmacology.
2026
Company · 2026
InfiniGraph opens select investor inquiries. We are moving fast and we are selective about who moves with us.
2026
"
We don't chase headlines. We publish results, timestamped and verified.
Chase K. McMichael · Founder & CEO · July 2026